Sun Pharma Discloses Schedule for September 2026 Institutional Investor Conferences
Sun Pharmaceutical Industries Ltd 路 Intimation 路 03 Sept 2026, 9:44 pm
Sun Pharma Discloses Schedule for September 2026 Institutional Investor Conferences Sun Pharmaceutical Industries announced its schedule for upcoming physical institutional investor meetings. Management will participate in the UBS India Summit (Mumbai) on 10th Sep'26, the Jefferies India Forum (Delhi) on 16th Sep'26, and the Kotak Healthcare Forum (Mumbai) on 17th Sep'26. Further Mumbai engagements include the J.P. Morgan India Conference on 21st Sep'26 and the Anand Rathi G-200 Summit on 22nd Sep'26. These events will involve group and one-on-one sessions. The company confirmed no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
